Lindahl U, Bäckström G, Höök M, Thunberg L, Fransson L A, Linker A
Proc Natl Acad Sci U S A. 1979 Jul;76(7):3198-202. doi: 10.1073/pnas.76.7.3198.
Heparin preparations from pig intestinal mucosa and from bovine lung were separated by chromatography on antithrombin-Sepharose into a high-affinity fraction (with high anticoagulant activity) and a low-affinity fraction (with low anticoagulant). Antithrombin-binding heparin fragments (12-16 monosaccharide units) were prepared, either by digesting a high-affinity heparin-antithrombin complex with bacterial heparinase or by partial deaminative cleavage of the unfractionated polysaccharide with nitrous acid followed by affinity chromatography on immobilized antithrombin. Compositional analysis based on separation and identification of deamination products reduced with sodium boro[3H]hydride showed that nonsulfated L-iduronic acid occurred in larger amounts in high-affinity heparin than in low-affinity heparin; furthermore, this component was concentrated in the antithrombin-binding regions of the high-affinity heparin molecules, amounting to approximately one residue per binding site. It is suggested that nonsulfated L-iduronic acid is essential for the anticoagulant activity of heparin. The location of the non-sulfated uronic acid in the antithrombin-binding site was determined by periodate oxidation of antithrombin-binding fragments containing a terminal 2,5-anhydro-D-[1-3H]mannitol unit. Tentative structures for antithrombin-binding sequences in heparin are proposed, including some structural variants believed to be compatible with, but not required for, activity.
来自猪肠黏膜和牛肺的肝素制剂通过抗凝血酶-琼脂糖凝胶色谱法分离为高亲和力组分(具有高抗凝活性)和低亲和力组分(具有低抗凝活性)。抗凝血酶结合型肝素片段(12 - 16个单糖单元)的制备方法有两种:一种是用细菌肝素酶消化高亲和力肝素-抗凝血酶复合物;另一种是先用亚硝酸对未分级的多糖进行部分脱氨基裂解,然后在固定化抗凝血酶上进行亲和色谱分离。基于硼氢化[3H]钠还原后的脱氨基产物的分离和鉴定进行的组成分析表明,高亲和力肝素中未硫酸化的L-艾杜糖醛酸含量比低亲和力肝素中的多;此外,该成分集中在高亲和力肝素分子的抗凝血酶结合区域,每个结合位点约有一个残基。有人提出,未硫酸化的L-艾杜糖醛酸对肝素的抗凝活性至关重要。通过对含有末端2,5-脱水-D-[1-3H]甘露糖醇单元的抗凝血酶结合片段进行高碘酸盐氧化,确定了抗凝血酶结合位点中未硫酸化糖醛酸的位置。文中提出了肝素中抗凝血酶结合序列的初步结构,包括一些据信与活性兼容但非活性必需的结构变体。